<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114211">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01772667</url>
  </required_header>
  <id_info>
    <org_study_id>Fibrosis2013</org_study_id>
    <nct_id>NCT01772667</nct_id>
  </id_info>
  <brief_title>Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis</brief_title>
  <official_title>Long Term Effects of a 3-week Inpatient Pulmonary Rehabilitation Program in Patients With Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Berchtesgadener Land der Schön-Kliniken</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum Berchtesgadener Land der Schön-Kliniken</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is evidence that an inpatient pulmonary rehabilitation of 3 weeks improves exercise
      capacity and quality of life in patients with idiopathic pulmonary fibrosis. However, there
      are no data available regarding long-term effects of this multimodal program. The aim of
      this study is to investigate the long-term impact of a rehabilitation program 3 month after
      finishing on exercise capacity and physical activity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Delta of 6-minute walking distance from 1 week pre rehabilitation to 3 month post rehabilitation</measure>
    <time_frame>1 week before rehabilitation to 3 month after finishing rehabilitation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delta of physical activity level from 1 week pre rehabilitation to 3 month post rehabilitation</measure>
    <time_frame>1 week before rehabilitation to 3 month after finishing rehabilitation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delta of SF36-score (questionnaire to measure quality of life) from 1 week pre to 3 month post rehabilitation</measure>
    <time_frame>1 week before rehabilitation to 3 month after finishing rehabilitation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care during the whole study period without pulmonary rehabilitation. The patients will perform their normal daily life.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inpatient Rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3-week inpatient multimodal pulmonary rehabilitation program, including daily exercise training, breathing therapy, medical treatment and psychological support. In the following 3 month, the patients will perform their normal daily life.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inpatient Rehabilitation</intervention_name>
    <description>Rehabilitation program in &quot;Schoen Klinik Berchtesgadener Land&quot;</description>
    <arm_group_label>Inpatient Rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  want to start a rehabilitation program in &quot;Schoen Klinik Berchtesgadener Land&quot;

          -  patients with idiopathic pulmonary fibrosis (vital capacity &gt; 50% pred.)

        Exclusion Criteria:

          -  exacerbation in the last 4 weeks
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Kenn, MD</last_name>
    <role>Study Director</role>
    <affiliation>Head physician in the department of pulmology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Klaus Kenn, MD</last_name>
    <phone>0049865293</phone>
    <phone_ext>1630</phone_ext>
    <email>kkenn@schoen-kliniken.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Schoen Klinik Berchtesgadener Land</name>
      <address>
        <city>Schoenau am Koenigssee</city>
        <state>Bavaria</state>
        <zip>83471</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Kenn, MD</last_name>
      <phone>+49 8652 931541</phone>
      <email>kkenn@schoen-kliniken.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 30, 2013</lastchanged_date>
  <firstreceived_date>January 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Berchtesgadener Land der Schön-Kliniken</investigator_affiliation>
    <investigator_full_name>Klaus Kenn</investigator_full_name>
    <investigator_title>Head physician of the Department of Pulmology</investigator_title>
  </responsible_party>
  <keyword>pulmonary fibrosis</keyword>
  <keyword>interstitial lung disease</keyword>
  <keyword>pulmonary rehabilitation</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>physical activity</keyword>
  <keyword>quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
